background sniper (R&D Systems)
91
Structured Review
R&D Systems
background sniper
Background Sniper, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/background+sniper+blocking+solution/Human+Dkk-1+Antibody/pm33129080-52-3-10
Average 91 stars, based on 8 article reviews
Background Sniper, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/background+sniper+blocking+solution/Human+Dkk-1+Antibody/pm33129080-52-3-10
Average 91 stars, based on 8 article reviews
background sniper - by Bioz Stars,
2026-11
91/100 stars
Images
Related Articles
Affinity Purification:Article Title: Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients Article Snippet: Sclerostin CA: monoclonal mouse IgG2B ahsclerostin antibody (R&D Systems (Minneapolis, MN) cat. no. MAB1406); sclerostin DA: biotinylated monoclonal mouse IgG1 ahsclerostin antibody (R&D Systems cat no. BAM1406), hRP (1406-ST-025). .. Dkk-1 CA: Enzyme-linked Immunosorbent Assay:Article Title: Decreased osteogenesis, increased cell senescence and elevated Dickkopf-1 secretion in human fracture non union stromal cells. Article Snippet: .. ELISA plates (IWAKI, Scientific Laboratory Supplies, Nottingham, UK) were incubated overnight at 4 °C with monoclonal Incubation:Article Title: Decreased osteogenesis, increased cell senescence and elevated Dickkopf-1 secretion in human fracture non union stromal cells. Article Snippet: .. ELISA plates (IWAKI, Scientific Laboratory Supplies, Nottingham, UK) were incubated overnight at 4 °C with monoclonal Article Title: A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation? Article Snippet: Background and aims: Clinical interventions targeting nonlipid risk factors are needed given the high residual risk of atherothrombotic events despite effective control of dyslipidemia.. Dickkopf-1 (DKK1) plays a lipidindependent role in vascular pathophysiology but its involvement in atherosclerosis development and its therapeutic attractiveness remain to be established.. Methods: Patient data, in vitro studies and pharmacological intervention in murine models of atherosclerosis were Blocking Assay:Article Title: A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation? Article Snippet: Background and aims: Clinical interventions targeting nonlipid risk factors are needed given the high residual risk of atherothrombotic events despite effective control of dyslipidemia.. Dickkopf-1 (DKK1) plays a lipidindependent role in vascular pathophysiology but its involvement in atherosclerosis development and its therapeutic attractiveness remain to be established.. Methods: Patient data, in vitro studies and pharmacological intervention in murine models of atherosclerosis were |